Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report

Fierce Pharma --------- GlaxoSmithKline and Reckitt Benckiser have already declared their interest in Pfizer’s consumer health unit. But they likely won’t be alone when bidding kicks off. Companies including Sanofi, Johnson & Johnson and Procter & Gamble could also look to snag the unit, sources told Reuters, and Pfizer’s hoping competition can help it reap at least $20 billion from a sale. The New York pharma giant plans to jump-start the auction process for the portfolio next month, they said, but Pfizer has already held talks with some suitors—including Reckitt. The company plans to send out financial info on its asset to wannabe buyers in about three weeks, and a deal could follow around the middle of next year, the news service reports. To learn more click on the picture below to read the article.